Pegylated liposomal doxorubicin augments the efficacy of engineered human T cells expressing a p53-specific T cell receptor against ovarian cancer

被引：1
|
作者：
Liao, J. [1 ]
Poussin, M. [2 ]
Hasegawa, K. [3 ]
Song, D. [2 ]
Powell, D. [2 ]
Coukos, G. [2 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Saitama Med Univ, Saitama, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2012年 / 125卷
关键词：
D O I：
10.1016/j.ygyno.2011.12.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [21] PSEUDOMONAS EXOTOXIN-ANTI-TAC - CELL-SPECIFIC IMMUNOTOXIN ACTIVE AGAINST CELLS EXPRESSING THE HUMAN T-CELL GROWTH-FACTOR RECEPTOR
    FITZGERALD, DJP
    WALDMANN, TA
    WILLINGHAM, MC
    PASTAN, I
    JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (03): : 966 - 971
  • [22] L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice
    Hong, Hao
    Brown, Christine E.
    Ostberg, Julie R.
    Priceman, Saul J.
    Chang, Wen-Chung
    Weng, Lihong
    Lin, Paul
    Wakabayashi, Mark T.
    Jensen, Michael C.
    Forman, Stephen J.
    PLOS ONE, 2016, 11 (01):
  • [23] Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
    Pinz, K.
    Liu, H.
    Golightly, M.
    Jares, A.
    Lan, F.
    Zieve, G. W.
    Hagag, N.
    Schuster, M.
    Firor, A. E.
    Jiang, X.
    Ma, Y.
    LEUKEMIA, 2016, 30 (03) : 701 - 707
  • [24] PiggyBac-engineered T cells expressing a glypican-3-specific chimeric antigen receptor show potent activities against hepatocellular carcinoma
    Wang, Pei
    Qin, Wenxia
    Liu, Tao
    Jiang, Duqing
    Cui, Lianzhen
    Liu, Xiangzhen
    Fang, Yuan
    Tang, Xi
    Jin, Huajun
    Qian, Qijun
    IMMUNOBIOLOGY, 2020, 225 (01)
  • [25] Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
    K Pinz
    H Liu
    M Golightly
    A Jares
    F Lan
    G W Zieve
    N Hagag
    M Schuster
    A E Firor
    X Jiang
    Y Ma
    Leukemia, 2016, 30 : 701 - 707
  • [26] Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties
    Balasiddaiah, Anangi
    Davanian, Haleh
    Aleman, Soo
    Pasetto, Anna
    Frelin, Lars
    Sallberg, Matti
    Lohmann, Volker
    Koh, Sarene
    Bertoletti, Antonio
    Chen, Margaret
    JOURNAL OF VIROLOGY, 2017, 91 (09)
  • [27] Epigenetic reprograming promotes an immunogenic ovarian tumor microenvironment and synergizes with adoptive transfer of engineered T cells expressing NY-ESO-1 specific T cell receptors.
    Shen, Li
    McGray, Bob
    Miliotto, Anthony
    Francois, Ariel
    Eppolito, Cheryl
    Matsuzaki, Junko
    Tsuji, Takemasa
    Koya, Richard
    Odunsi, Adekunle
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 35 - 35
  • [28] Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
    Lionel Low
    Angeline Goh
    Joanna Koh
    Samantha Lim
    Cheng-I Wang
    Nature Communications, 10
  • [29] Targeting mutant p53-expressing tumours with a T cell receptor-like antibody specific for a wild-type antigen
    Low, Lionel
    Goh, Angeline
    Koh, Joanna
    Lim, Samantha
    Wang, Cheng-I
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [30] Redirecting mouse T hybridoma against human breast and ovarian carcinomas: in vivo activity against HER-2/neu expressing cancer cells
    A D Gritzapis
    A Mamalaki
    A Kretsovali
    J Papamatheakis
    M Belimezi
    S A Perez
    C N Baxevanis
    M Papamichail
    British Journal of Cancer, 2003, 88 : 1292 - 1300
12345